Medibase
EN VI JA

Medical devices

Price management

Price posting and transparency obligations for medical devices under Decree 98/2021/NĐ-CP and the public MOH price portal.

Overview

Medical-device pricing in Vietnam follows a market-mechanism approach: businesses set prices freely, but Decree 98/2021/NĐ-CP and its amendments impose transparency obligations to deter overpricing in hospital procurement.

Core obligations:

  • Price posting at the place of sale and on the business's electronic channels.
  • Public price posting on the MOH-operated electronic information portal — applies to medical devices that fall within the scope of price-declaration rules. The MAC holder or authorised distributor is responsible for keeping the posted price current.
  • No selling above the posted price — selling at a price higher than the publicly posted price is a violation subject to administrative penalty.

For products procured by public hospitals, the price posted on the MOH portal is the reference point for tender bid evaluation and for the Vietnam Social Security audit of facility purchases. Posting an unjustifiably high price exposes the seller to reputational and tender-eligibility risk even before formal penalty.

Foreign-manufactured devices: the importer responsible for the product in Vietnam is the posting party. The posting must reconcile with import-value declarations to Customs.

Cross-reference: for public procurement of medical devices including IVD reagents, see Medicine → Tendering & Market Access (Article 55 of the 2023 Bidding Law has medicine and medical-equipment provisions in a single framework).

Key documents

Core framework:

  • Decree 98/2021/NĐ-CP — Chapter on price management; mandates price posting and the role of the public MOH price portal.
  • Decree 07/2023/NĐ-CP — issued 3 March 2023. Amends Decree 98/2021, including refinements to the price-posting rules and grace periods after the post-pandemic shortage.
  • Circular 05/2022/TT-BYT — implementation details, including posting format.

Related (procurement):

  • Law on Bidding 22/2023/QH15 (Article 55) — special procurement regime for medicines and medical devices in public healthcare. See Medicine → Tendering & Market Access.
  • Decree 24/2024/NĐ-CP — implements the Bidding Law for contractor selection, with chapter on pharmaceutical and medical-device procurement.

Penalties:

  • Decree 117/2020/NĐ-CP and Decree 124/2021/NĐ-CP — administrative penalties in the health sector including failure to post or correctly maintain medical-device prices.

Recent updates

2024 — Bidding Law and Decree 24/2024 in force: Article 55 of the 2023 Bidding Law (effective 1 January 2024) and implementing Decree 24/2024/NĐ-CP (27 February 2024) created a unified medicines-and-devices procurement regime; medical-device price posting feeds directly into public-tender evaluation.

2023 — Decree 07/2023 price-posting refinements: Clarified posting responsibilities and provided transitional relief where shortage-driven price changes risked violation of the prior posting rule.

Standing — Cross-checking on tender pages: VFA, Vietnam Social Security, and the National Centralized Drug Procurement Center cross-check posted prices against winning tender prices for medical equipment; significant gaps trigger scrutiny.

Resources & links

Public price portals:

  • MOH medical-device price portal — operated under Decree 98/2021. Search posted prices by device name, MAC number, manufacturer, importer.
  • Public health portal (Cổng công khai y tế) — https://congkhaiyte.moh.gov.vn — aggregates device prices and tender results.
  • National e-Procurement System — https://muasamcong.mpi.gov.vn — public tender notices and award results for hospital procurement.

Government & regulator:

  • Infrastructure and Medical Device Administration (IMDA, MOH).
  • Vietnam Social Security (BHXH) — https://baohiemxahoi.gov.vn — funding and oversight of hospital device purchases.
  • Market Surveillance (Tổng cục Quản lý thị trường) — https://dms.gov.vn — enforcement against retail-price violations.

Reference & official text:

Legal basis

See the full legal register →

Page updated:
2026-08-16

Related topics — Medical devices

Market access & licensing

Marketing authorisation (số lưu hành) and import licensing for medical devices in Vietnam, with the ASEAN CSDT pathway and reference-country fast track.

Medical Device Registration Process in Vietnam

End-to-end operational analysis of medical-device registration in Vietnam under Decree 98/2021/NĐ-CP, as amended by Decree 07/2023/NĐ-CP, Decree 96/2023/NĐ-CP, and Decree 04/2025/NĐ-CP (in force 1 January 2025) — Class A published-declaration track at provincial Sở Y tế, Class B/C/D Marketing Authorisation Certificate (số lưu hành) track at MOH/DMEC, ASEAN CSDT structure, reference-country fast track, statutory vs real-world timelines, and the 2022–2024 backlog crisis that drove the reform package.

Medical Device Labelling in Vietnam

Mandatory label content in Vietnamese, supplementary labels for imports, registration-number identification, expiry and lot, symbols and warnings, e-IFU rules and 2026 changes under Decree 37/2026/NĐ-CP (in force 23 January 2026; replaces Decree 43/2017 + Decree 111/2021), plus device-specific rules under Decree 98/2021/NĐ-CP (as amended by 07/2023, 96/2023 and 04/2025) and Circular 05/2022/TT-BYT.

Post-market & quality control

Vigilance, incident reporting, recalls, QMS (ISO 13485), and IMDA inspections for medical devices on the Vietnamese market.

Vietnam IVD & SaMD Regulation: Classification, Approval, Labelling

In-vitro diagnostic devices and software as a medical device in Vietnam: risk classification (Class A/B/C/D), approval workflow, expedited SRA pathway, product grouping, analytical + clinical testing evidence, labelling, and the SaMD guidance gap — under Decree 98/2021/NĐ-CP (as amended by Decree 07/2023, 96/2023 and 04/2025) and Circular 05/2022/TT-BYT.

Medical Device Import & Export in Vietnam

Risk-classified import and export of medical devices and IVDs under Decree 98/2021/NĐ-CP as amended by Decree 07/2023/NĐ-CP and Decree 04/2025/NĐ-CP, the IMDA registration regime, the Hague Apostille Convention from 11 September 2026, and the open WTO regime for foreign-invested distributors — a fully separate legal chain from the drug regime.

Back to Medical devices

Reference information only; not legal or medical advice.